{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T11:04:51Z","timestamp":1781003091458,"version":"3.54.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,17]],"date-time":"2025-08-17T00:00:00Z","timestamp":1755388800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"publisher","award":["NNF23OC0085612"],"award-info":[{"award-number":["NNF23OC0085612"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinejcf.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiac Failure"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.cardfail.2025.07.013","type":"journal-article","created":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T14:55:17Z","timestamp":1754751317000},"page":"1050-1058","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Should Exogenous Ketone Body Supplementation Be Considered in Patients Hospitalized for Acute Heart Failure? Rationale and Design of the KETO-AHF Trial"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5110-0656","authenticated-orcid":false,"given":"KRISTOFFER","family":"BERG-HANSEN","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ANDREAS BUGGE","family":"TINGGAARD","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RONI","family":"NIELSEN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"THOMAS HVID","family":"JENSEN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"NIGOPAN","family":"GOPALASINGAM","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ANDERS HOSTRUP","family":"LARSEN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"NIELS","family":"M\u00d8LLER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MORTEN","family":"B\u00d6TTCHER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MALENE","family":"HOLLINGDAL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MIKAEL KJ\u00c6R","family":"POULSEN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LISBETH","family":"ANTONSEN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TORU","family":"KONDO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PARDEEP S.","family":"JHUND","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BARRY A.","family":"BORLAUG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ALEXANDRE","family":"MEBAZAA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JACOB EIFER","family":"M\u00d8LLER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00d8REN","family":"VRAA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JOHANNES","family":"GRAND","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JENS DAHLGAARD","family":"HOVE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"EMIL","family":"WOLSK","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MORTEN","family":"SCHOU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HENRIK","family":"WIGGERS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cardfail.2025.07.013_bib0001","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2174\/1573403X11309020005","article-title":"Heart failure epidemiology: European perspective","volume":"9","author":"Guha","year":"2013","journal-title":"Curr Cardiol Rev"},{"key":"10.1016\/j.cardfail.2025.07.013_bib0002","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2025.07.013_bib0003","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1161\/CIRCULATIONAHA.119.045033","article-title":"Implications of altered ketone metabolism and therapeutic ketosis in heart failure","volume":"141","author":"Selvaraj","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2025.07.013_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2020.154452","article-title":"Myocardial ketone body utilization in patients with heart failure: the impact of oral ketone ester","volume":"115","author":"Monzo","year":"2021","journal-title":"Metabolism"},{"key":"10.1016\/j.cardfail.2025.07.013_bib0005","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1161\/CIRCRESAHA.121.318241","article-title":"Cardiac energy metabolism in heart failure","author":"Lopaschuk","year":"2021","journal-title":"Circ Res"},{"key":"10.1016\/j.cardfail.2025.07.013_bib0006","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1161\/CIRCULATIONAHA.115.017545","article-title":"Evidence for intramyocardial disruption of lipid metabolism and increased myocardial ketone utilization in advanced human heart failure","volume":"133","author":"Bedi","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2025.07.013_bib0007","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1161\/CIRCULATIONAHA.118.036459","article-title":"Cardiovascular effects of treatment with the ketone body 3-hydroxybutyrate in chronic heart failure patients","volume":"139","author":"Nielsen","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2025.07.013_bib0008","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1161\/CIRCULATIONAHA.123.067971","article-title":"Cardiovascular effects of oral ketone ester treatment in patients with heart failure with reduced ejection fraction: a randomized, controlled, double-blind trial","volume":"149","author":"Berg-Hansen","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2025.07.013_bib0009","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.jchf.2023.05.029","article-title":"Beneficial effects of ketone ester in patients with cardiogenic shock: a randomized, controlled, double-blind trial","volume":"11","author":"Berg-Hansen","year":"2023","journal-title":"JACC Hear Fail"},{"issue":"1","key":"10.1016\/j.cardfail.2025.07.013_bib0010","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.124.038461","article-title":"Cardiovascular and metabolic effects of modulating circulating ketone bodies with 1,3-butanediol in patients with heart failure with reduced ejection fraction","volume":"14","author":"Guldbrandsen","year":"2025","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cardfail.2025.07.013_bib0011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphys.2023.1195702","article-title":"An open-label, acute clinical trial in adults to assess ketone levels, gastrointestinal tolerability, and sleepiness following consumption of (R)-1,3-butanediol (AvelaTM)","volume":"14","author":"Lowder","year":"2023","journal-title":"Front Physiol"},{"key":"10.1016\/j.cardfail.2025.07.013_bib0012","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.cardfail.2017.07.402","article-title":"Run-in periods in randomized clinical trials","volume":"23","author":"Schechtman","year":"2017","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2025.07.013_bib0013","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.cardfail.2022.10.423","article-title":"Minimal clinically important differences in 6-minute walk test in patients with HFrEF and iron deficiency: MCID for 6MWT in patients with HFrEF and iron deficiency","volume":"29","author":"Khan","year":"2023","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2025.07.013_bib0014","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1161\/01.CIR.0000144310.04433.BE","article-title":"N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients","volume":"110","author":"Bettencourt","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2025.07.013_bib0015","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/ehjci\/jeab227","article-title":"Myocardial efficiency in patients with different aetiologies and stages of heart failure","volume":"23","author":"Hansen","year":"2022","journal-title":"Eur Heart J Cardiovasc Imag"},{"key":"10.1016\/j.cardfail.2025.07.013_bib0016","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1152\/physrev.1980.60.1.143","article-title":"Physiological roles of ketone bodies as substrates and signals in mammalian tissues","volume":"60","author":"Robinson","year":"1980","journal-title":"Physiol Rev"},{"key":"10.1016\/j.cardfail.2025.07.013_bib0017","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.028232","article-title":"Hemodynamic effects of ketone bodies in patients with pulmonary hypertension","author":"Nielsen","year":"2023","journal-title":"J Am Heart Assoc"},{"issue":"20","key":"10.1016\/j.cardfail.2025.07.013_bib0018","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1161\/CIRCULATIONAHA.124.069732","article-title":"Randomized crossover trial of 2-week ketone ester treatment in patients with type 2 diabetes and heart failure with preserved ejection fraction","volume":"150","author":"Gopalasingam","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2025.07.013_bib0019","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/nrcardio.2015.14","article-title":"The vulnerable phase after hospitalization for heart failure","volume":"12","author":"Greene","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.cardfail.2025.07.013_bib0020","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1161\/CIRCULATIONAHA.122.062166","article-title":"Retained Metabolic Flexibility of the Failing Human Heart","volume":"148","author":"Watson","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2025.07.013_bib0021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/JAHA.123.029849","article-title":"Stimulation of the hydroxycarboxylic acid receptor 2 with the ketone body 3-hydroxybutyrate and niacin in patients with chronic heart failure: hemodynamic and metabolic effects","volume":"12","author":"Gopalasingam","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cardfail.2025.07.013_bib0022","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00395-023-01008-y","article-title":"Ketone body 3-hydroxybutyrate elevates cardiac output through peripheral vasorelaxation and enhanced cardiac contractility","volume":"118","author":"Homilius","year":"2023","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.cardfail.2025.07.013_bib0023","article-title":"Neurohormonal and renal effects of 14-day oral ketone ester treatment in patients with heart failure with reduced ejection fraction","author":"Berg-Hansen","year":"2024","journal-title":"Circ Heart Fail"},{"issue":"8","key":"10.1016\/j.cardfail.2025.07.013_bib0024","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.033628","article-title":"Enantiomer-specific cardiovascular effects of the ketone body 3-hydroxybutyrate","volume":"13","author":"Gopalasingam","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cardfail.2025.07.013_bib0025","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1161\/CIRCULATIONAHA.118.034986","article-title":"Incidence of hospitalization for heart failure and case-fatality among 3.25 million people with and without diabetes mellitus","volume":"138","author":"McAllister","year":"2018","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.cardfail.2025.07.013_bib0026","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.2337\/db25-0243","article-title":"The cardiac and hemodynamic effects of ketone bodies are abnormal in patients with type 1 diabetes: a randomized controlled trial","volume":"74","author":"Berg-Hansen","year":"2025","journal-title":"Diabetes"},{"key":"10.1016\/j.cardfail.2025.07.013_bib0027","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s00395-025-01103-2","article-title":"The ketone body 3-hydroxybutyrate increases cardiac output and cardiac contractility in a porcine model of cardiogenic shock: a randomized, blinded, crossover trial","volume":"120","author":"H\u00f8rsdal","year":"2025","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.cardfail.2025.07.013_bib0028","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/ejhf.2137","article-title":"Sodium-glucose co-transporter 2 inhibition in patients hospitalized for acute decompensated heart failure: rationale for and design of the EMPULSE trial","volume":"23","author":"Tromp","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2025.07.013_bib0029","doi-asserted-by":"crossref","first-page":"4684","DOI":"10.1093\/eurheartj\/ehae647","article-title":"The win ratio in cardiology trials: lessons learnt, new developments, and wise future use","volume":"45","author":"Pocock","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2025.07.013_bib0030","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1161\/CIRCULATIONAHA.117.033502","article-title":"2017 cardiovascular and stroke endpoint definitions for clinical trials","volume":"137","author":"Hicks","year":"2018","journal-title":"Circulation"}],"container-title":["Journal of Cardiac Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916425003331?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916425003331?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T10:54:48Z","timestamp":1781002488000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071916425003331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S1071916425003331"],"URL":"https:\/\/doi.org\/10.1016\/j.cardfail.2025.07.013","relation":{},"ISSN":["1071-9164"],"issn-type":[{"value":"1071-9164","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Should Exogenous Ketone Body Supplementation Be Considered in Patients Hospitalized for Acute Heart Failure? Rationale and Design of the KETO-AHF Trial","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiac Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cardfail.2025.07.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}